Rank | Gene Set | Z-score |
---|---|---|
1 | exogenous drug catabolic process (GO:0042738) | 9.50539774 |
2 | omega-hydroxylase P450 pathway (GO:0097267) | 9.15147269 |
3 | epoxygenase P450 pathway (GO:0019373) | 8.97399588 |
4 | L-phenylalanine catabolic process (GO:0006559) | 7.73146519 |
5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.73146519 |
6 | L-phenylalanine metabolic process (GO:0006558) | 7.36349931 |
7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.36349931 |
8 | aromatic amino acid family catabolic process (GO:0009074) | 7.02872905 |
9 | tryptophan catabolic process (GO:0006569) | 6.42909753 |
10 | indole-containing compound catabolic process (GO:0042436) | 6.42909753 |
11 | indolalkylamine catabolic process (GO:0046218) | 6.42909753 |
12 | bile acid biosynthetic process (GO:0006699) | 6.27594355 |
13 | kynurenine metabolic process (GO:0070189) | 6.23139329 |
14 | drug metabolic process (GO:0017144) | 6.16437572 |
15 | tryptophan metabolic process (GO:0006568) | 6.03390633 |
16 | oxidative demethylation (GO:0070989) | 5.91790907 |
17 | glyoxylate metabolic process (GO:0046487) | 5.90975304 |
18 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.88820579 |
19 | urea metabolic process (GO:0019627) | 5.82308948 |
20 | urea cycle (GO:0000050) | 5.82308948 |
21 | * regulation of protein activation cascade (GO:2000257) | 5.77477870 |
22 | negative regulation of fibrinolysis (GO:0051918) | 5.73273364 |
23 | * complement activation, alternative pathway (GO:0006957) | 5.60929294 |
24 | regulation of fibrinolysis (GO:0051917) | 5.59292171 |
25 | regulation of plasminogen activation (GO:0010755) | 5.55677864 |
26 | ethanol metabolic process (GO:0006067) | 5.54392043 |
27 | protein carboxylation (GO:0018214) | 5.48598009 |
28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.48598009 |
29 | * regulation of complement activation (GO:0030449) | 5.42397306 |
30 | cysteine metabolic process (GO:0006534) | 5.42241775 |
31 | sulfur amino acid catabolic process (GO:0000098) | 5.39435754 |
32 | nitrogen cycle metabolic process (GO:0071941) | 5.35339243 |
33 | alpha-linolenic acid metabolic process (GO:0036109) | 5.31322566 |
34 | high-density lipoprotein particle remodeling (GO:0034375) | 5.26583325 |
35 | bile acid metabolic process (GO:0008206) | 5.19683710 |
36 | aromatic amino acid family metabolic process (GO:0009072) | 5.09306368 |
37 | serine family amino acid catabolic process (GO:0009071) | 5.06212215 |
38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.98370384 |
39 | homocysteine metabolic process (GO:0050667) | 4.94788701 |
40 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.89106924 |
41 | * regulation of humoral immune response (GO:0002920) | 4.85841156 |
42 | phenylpropanoid metabolic process (GO:0009698) | 4.83972324 |
43 | negative regulation of blood coagulation (GO:0030195) | 4.83103284 |
44 | negative regulation of hemostasis (GO:1900047) | 4.83103284 |
45 | tyrosine metabolic process (GO:0006570) | 4.82672994 |
46 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.80614180 |
47 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.80614180 |
48 | regulation of triglyceride catabolic process (GO:0010896) | 4.77883313 |
49 | alpha-amino acid catabolic process (GO:1901606) | 4.66175240 |
50 | lysine metabolic process (GO:0006553) | 4.65936146 |
51 | lysine catabolic process (GO:0006554) | 4.65936146 |
52 | reverse cholesterol transport (GO:0043691) | 4.64932511 |
53 | coenzyme catabolic process (GO:0009109) | 4.63079087 |
54 | plasma lipoprotein particle remodeling (GO:0034369) | 4.56750813 |
55 | protein-lipid complex remodeling (GO:0034368) | 4.56750813 |
56 | macromolecular complex remodeling (GO:0034367) | 4.56750813 |
57 | indolalkylamine metabolic process (GO:0006586) | 4.56502696 |
58 | acylglycerol homeostasis (GO:0055090) | 4.55655924 |
59 | triglyceride homeostasis (GO:0070328) | 4.55655924 |
60 | bile acid and bile salt transport (GO:0015721) | 4.46739805 |
61 | amino-acid betaine metabolic process (GO:0006577) | 4.46193343 |
62 | regulation of cholesterol esterification (GO:0010872) | 4.45918595 |
63 | S-adenosylmethionine metabolic process (GO:0046500) | 4.44310860 |
64 | amine catabolic process (GO:0009310) | 4.43090774 |
65 | cellular biogenic amine catabolic process (GO:0042402) | 4.43090774 |
66 | glycine metabolic process (GO:0006544) | 4.41961020 |
67 | negative regulation of coagulation (GO:0050819) | 4.38878844 |
68 | negative regulation of wound healing (GO:0061045) | 4.36373960 |
69 | imidazole-containing compound metabolic process (GO:0052803) | 4.34794933 |
70 | cellular amino acid catabolic process (GO:0009063) | 4.28980781 |
71 | phospholipid efflux (GO:0033700) | 4.26677722 |
72 | positive regulation of blood coagulation (GO:0030194) | 4.24780558 |
73 | positive regulation of hemostasis (GO:1900048) | 4.24780558 |
74 | glutamate metabolic process (GO:0006536) | 4.24240633 |
75 | cellular glucuronidation (GO:0052695) | 4.23719292 |
76 | serine family amino acid metabolic process (GO:0009069) | 4.19965366 |
77 | cellular ketone body metabolic process (GO:0046950) | 4.19365991 |
78 | plasma lipoprotein particle clearance (GO:0034381) | 4.18741524 |
79 | negative regulation of cholesterol transport (GO:0032375) | 4.17981662 |
80 | negative regulation of sterol transport (GO:0032372) | 4.17981662 |
81 | fibrinolysis (GO:0042730) | 4.12450095 |
82 | benzene-containing compound metabolic process (GO:0042537) | 4.11283036 |
83 | cellular modified amino acid catabolic process (GO:0042219) | 4.10551081 |
84 | ethanol oxidation (GO:0006069) | 4.10436433 |
85 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.08340588 |
86 | cholesterol efflux (GO:0033344) | 4.04653737 |
87 | * cytolysis (GO:0019835) | 4.00199848 |
88 | arginine metabolic process (GO:0006525) | 3.99500145 |
89 | aldehyde catabolic process (GO:0046185) | 3.98706604 |
90 | * complement activation, classical pathway (GO:0006958) | 3.98523328 |
91 | negative regulation of complement activation (GO:0045916) | 3.98034913 |
92 | blood coagulation, intrinsic pathway (GO:0007597) | 3.96723489 |
93 | alkaloid metabolic process (GO:0009820) | 3.94694427 |
94 | serine family amino acid biosynthetic process (GO:0009070) | 3.94577430 |
95 | * complement activation (GO:0006956) | 3.92297524 |
96 | positive regulation of coagulation (GO:0050820) | 3.89041533 |
97 | cofactor catabolic process (GO:0051187) | 3.88910769 |
98 | * protein activation cascade (GO:0072376) | 3.87188921 |
99 | acute inflammatory response (GO:0002526) | 3.83906568 |
100 | plasma lipoprotein particle assembly (GO:0034377) | 3.81585084 |
101 | regulation of bile acid biosynthetic process (GO:0070857) | 3.78976619 |
102 | acetyl-CoA metabolic process (GO:0006084) | 3.77832564 |
103 | uronic acid metabolic process (GO:0006063) | 3.76675115 |
104 | glucuronate metabolic process (GO:0019585) | 3.76675115 |
105 | low-density lipoprotein particle remodeling (GO:0034374) | 3.76308742 |
106 | hormone catabolic process (GO:0042447) | 3.76248723 |
107 | regulation of apoptotic cell clearance (GO:2000425) | 3.75560735 |
108 | negative regulation of protein activation cascade (GO:2000258) | 3.72495883 |
109 | phospholipid homeostasis (GO:0055091) | 3.70625229 |
110 | carboxylic acid catabolic process (GO:0046395) | 3.70088159 |
111 | organic acid catabolic process (GO:0016054) | 3.70088159 |
112 | flavonoid metabolic process (GO:0009812) | 3.67355683 |
113 | cholesterol homeostasis (GO:0042632) | 3.67037682 |
114 | regulation of cholesterol homeostasis (GO:2000188) | 3.64259906 |
115 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.63038874 |
116 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.63038874 |
117 | ketone body metabolic process (GO:1902224) | 3.62577839 |
118 | sterol homeostasis (GO:0055092) | 3.61049021 |
119 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.60594312 |
120 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.59074743 |
121 | drug catabolic process (GO:0042737) | 3.55808033 |
122 | acute-phase response (GO:0006953) | 3.55504425 |
123 | NAD biosynthetic process (GO:0009435) | 3.55152251 |
124 | positive regulation of lipid catabolic process (GO:0050996) | 3.54759218 |
125 | intestinal cholesterol absorption (GO:0030299) | 3.54628125 |
126 | opsonization (GO:0008228) | 3.53050353 |
127 | negative regulation of lipase activity (GO:0060192) | 3.51878715 |
128 | heme transport (GO:0015886) | 3.51696398 |
129 | sodium-independent organic anion transport (GO:0043252) | 3.45021198 |
130 | * regulation of acute inflammatory response (GO:0002673) | 3.40570535 |
131 | response to mercury ion (GO:0046689) | 3.40565186 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.29572332 |
2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.21369956 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.13709630 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.43769758 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.33367979 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.13620226 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.43359419 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.11462128 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.07258081 |
10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.57773296 |
11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.05948928 |
12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0211820 |
13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.95562625 |
14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.90748369 |
15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.63918555 |
16 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62277382 |
17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.60433135 |
18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.50209564 |
19 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.44098391 |
20 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39956075 |
21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.33141151 |
22 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.22832739 |
23 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.20486793 |
24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.17184993 |
25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16567595 |
26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.15392668 |
27 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.13497564 |
28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.10481792 |
29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.06284944 |
30 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00431287 |
31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97445269 |
32 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.91883350 |
33 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.91716656 |
34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.91216531 |
35 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.86155656 |
36 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.81927193 |
37 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.81186632 |
38 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79680246 |
39 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.77797651 |
40 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.76213832 |
41 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.75560010 |
42 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.75161980 |
43 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75050462 |
44 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.74968841 |
45 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74868765 |
46 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.74672269 |
47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.73940929 |
48 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.73622874 |
49 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.72929259 |
50 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.72713120 |
51 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71340780 |
52 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.71148020 |
53 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.70268605 |
54 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.70046011 |
55 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.69688620 |
56 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69457158 |
57 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.68392578 |
58 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.68392578 |
59 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.67961724 |
60 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.67773921 |
61 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.67265965 |
62 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.66725610 |
63 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.65665119 |
64 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.64339662 |
65 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.62122246 |
66 | * NFYA_21822215_ChIP-Seq_K562_Human | 0.62090840 |
67 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.61067270 |
68 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.60659006 |
69 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.60571407 |
70 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.60507913 |
71 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.60434563 |
72 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.59604429 |
73 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59538957 |
74 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.59095317 |
75 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.56912574 |
76 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.56534152 |
77 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.55450277 |
78 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.54231226 |
79 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.53884419 |
80 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.53657925 |
81 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.53559669 |
82 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.53095536 |
83 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.52909422 |
84 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.52896997 |
85 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51974386 |
86 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51595964 |
87 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.51357566 |
88 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.50922128 |
89 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.50647041 |
90 | CBP_21632823_ChIP-Seq_H3396_Human | 0.50445976 |
91 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.50404457 |
92 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.49993096 |
93 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49817077 |
94 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.49270687 |
95 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.49182083 |
96 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.49020192 |
97 | * ETV1_20927104_ChIP-Seq_GIST48_Human | 0.48980204 |
98 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.48726218 |
99 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.48677444 |
100 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.48520243 |
101 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.48383336 |
102 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.48311999 |
103 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.48268086 |
104 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.47971075 |
105 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.47910193 |
106 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.47061223 |
107 | * ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.47048892 |
108 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.46480521 |
109 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.46038781 |
110 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.45699912 |
111 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.45634817 |
112 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.45067819 |
113 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.44969208 |
114 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.43616430 |
115 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.43460677 |
116 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.43315417 |
117 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.41327634 |
118 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40421241 |
119 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.40133208 |
120 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.39779735 |
121 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.39541216 |
122 | * ERG_20517297_ChIP-Seq_VCAP_Human | 0.39397855 |
123 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.39192332 |
124 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.39097582 |
125 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.39039574 |
126 | GATA1_19941826_ChIP-Seq_K562_Human | 0.38734661 |
127 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.38676732 |
128 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.38377194 |
129 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.36384292 |
130 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.35992876 |
131 | NCOR_22424771_ChIP-Seq_293T_Human | 0.35989461 |
132 | GATA2_19941826_ChIP-Seq_K562_Human | 0.35734234 |
133 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.35507517 |
134 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35210178 |
135 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.34896570 |
136 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.34447063 |
137 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.34146597 |
138 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.33851272 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.11827286 |
2 | MP0005360_urolithiasis | 7.62541733 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.54655943 |
4 | MP0005365_abnormal_bile_salt | 6.26003226 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.86714445 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.30011410 |
7 | MP0003252_abnormal_bile_duct | 4.04590932 |
8 | MP0010329_abnormal_lipoprotein_level | 3.53158672 |
9 | MP0009840_abnormal_foam_cell | 3.03009196 |
10 | MP0005083_abnormal_biliary_tract | 3.00512921 |
11 | MP0003195_calcinosis | 2.99897161 |
12 | MP0005332_abnormal_amino_acid | 2.75827163 |
13 | MP0001666_abnormal_nutrient_absorption | 2.63923737 |
14 | MP0003191_abnormal_cellular_cholesterol | 2.24401343 |
15 | MP0000609_abnormal_liver_physiology | 2.15657879 |
16 | MP0004019_abnormal_vitamin_homeostasis | 2.13362589 |
17 | MP0003868_abnormal_feces_composition | 2.11346041 |
18 | MP0002118_abnormal_lipid_homeostasis | 2.07237889 |
19 | MP0002138_abnormal_hepatobiliary_system | 2.03223173 |
20 | MP0005319_abnormal_enzyme/_coenzyme | 1.83980232 |
21 | MP0001764_abnormal_homeostasis | 1.73325580 |
22 | MP0009697_abnormal_copulation | 1.60152210 |
23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.52985514 |
24 | MP0003011_delayed_dark_adaptation | 1.38171545 |
25 | MP0009643_abnormal_urine_homeostasis | 1.26153740 |
26 | MP0002132_abnormal_respiratory_system | 1.25111171 |
27 | MP0003656_abnormal_erythrocyte_physiolo | 1.25004382 |
28 | MP0003186_abnormal_redox_activity | 1.22927110 |
29 | MP0000598_abnormal_liver_morphology | 1.18529698 |
30 | MP0005647_abnormal_sex_gland | 1.18527090 |
31 | MP0003705_abnormal_hypodermis_morpholog | 1.12543435 |
32 | MP0005451_abnormal_body_composition | 1.10873139 |
33 | MP0010368_abnormal_lymphatic_system | 1.02490911 |
34 | MP0009763_increased_sensitivity_to | 1.01556281 |
35 | MP0005636_abnormal_mineral_homeostasis | 1.00610249 |
36 | MP0002254_reproductive_system_inflammat | 0.99999397 |
37 | MP0009764_decreased_sensitivity_to | 0.99454682 |
38 | MP0000604_amyloidosis | 0.98091064 |
39 | MP0005408_hypopigmentation | 0.94819863 |
40 | MP0005220_abnormal_exocrine_pancreas | 0.94185882 |
41 | MP0005084_abnormal_gallbladder_morpholo | 0.92866826 |
42 | MP0002282_abnormal_trachea_morphology | 0.92531194 |
43 | MP0008469_abnormal_protein_level | 0.91933675 |
44 | MP0005670_abnormal_white_adipose | 0.89349385 |
45 | MP0009642_abnormal_blood_homeostasis | 0.87709453 |
46 | MP0001915_intracranial_hemorrhage | 0.86892999 |
47 | MP0002078_abnormal_glucose_homeostasis | 0.83726974 |
48 | MP0006036_abnormal_mitochondrial_physio | 0.80090617 |
49 | MP0005376_homeostasis/metabolism_phenot | 0.79435413 |
50 | MP0002876_abnormal_thyroid_physiology | 0.75983360 |
51 | MP0009765_abnormal_xenobiotic_induced | 0.75019153 |
52 | MP0005535_abnormal_body_temperature | 0.71325013 |
53 | MP0005187_abnormal_penis_morphology | 0.71241452 |
54 | MP0002249_abnormal_larynx_morphology | 0.71041865 |
55 | MP0004130_abnormal_muscle_cell | 0.70283860 |
56 | MP0002971_abnormal_brown_adipose | 0.69436442 |
57 | MP0005334_abnormal_fat_pad | 0.67231973 |
58 | MP0000639_abnormal_adrenal_gland | 0.67197513 |
59 | MP0003879_abnormal_hair_cell | 0.66586112 |
60 | MP0001756_abnormal_urination | 0.64869945 |
61 | MP0005266_abnormal_metabolism | 0.64815343 |
62 | MP0001661_extended_life_span | 0.61667693 |
63 | MP0004381_abnormal_hair_follicle | 0.60918641 |
64 | MP0005023_abnormal_wound_healing | 0.60858627 |
65 | MP0002837_dystrophic_cardiac_calcinosis | 0.60302435 |
66 | MP0003690_abnormal_glial_cell | 0.60204787 |
67 | MP0009785_altered_susceptibility_to | 0.59411851 |
68 | MP0009053_abnormal_anal_canal | 0.58819300 |
69 | MP0005448_abnormal_energy_balance | 0.54724582 |
70 | MP0009384_cardiac_valve_regurgitation | 0.54470121 |
71 | MP0002928_abnormal_bile_duct | 0.54384682 |
72 | MP0006035_abnormal_mitochondrial_morpho | 0.53899744 |
73 | MP0003329_amyloid_beta_deposits | 0.53569245 |
74 | MP0005395_other_phenotype | 0.49161157 |
75 | MP0000579_abnormal_nail_morphology | 0.49029034 |
76 | MP0003718_maternal_effect | 0.47471888 |
77 | MP0009379_abnormal_foot_pigmentation | 0.46526733 |
78 | MP0003724_increased_susceptibility_to | 0.45683279 |
79 | MP0005164_abnormal_response_to | 0.44900131 |
80 | MP0005464_abnormal_platelet_physiology | 0.44890509 |
81 | MP0004883_abnormal_blood_vessel | 0.44843408 |
82 | MP0000249_abnormal_blood_vessel | 0.43885898 |
83 | MP0003953_abnormal_hormone_level | 0.43777569 |
84 | MP0004782_abnormal_surfactant_physiolog | 0.43346357 |
85 | MP0002136_abnormal_kidney_physiology | 0.43280979 |
86 | MP0005166_decreased_susceptibility_to | 0.43036648 |
87 | MP0003638_abnormal_response/metabolism_ | 0.42513278 |
88 | MP0000566_synostosis | 0.42501517 |
89 | MP0008873_increased_physiological_sensi | 0.41937965 |
90 | MP0009672_abnormal_birth_weight | 0.39414660 |
91 | MP0002822_catalepsy | 0.38369942 |
92 | MP0008874_decreased_physiological_sensi | 0.37175044 |
93 | MP0005666_abnormal_adipose_tissue | 0.36949870 |
94 | MP0000467_abnormal_esophagus_morphology | 0.36833499 |
95 | MP0001944_abnormal_pancreas_morphology | 0.36628472 |
96 | MP0002796_impaired_skin_barrier | 0.36120941 |
97 | MP0003436_decreased_susceptibility_to | 0.35949189 |
98 | MP0003075_altered_response_to | 0.35843162 |
99 | MP0000230_abnormal_systemic_arterial | 0.35259914 |
100 | MP0005075_abnormal_melanosome_morpholog | 0.35095196 |
101 | MP0004264_abnormal_extraembryonic_tissu | 0.34582309 |
102 | MP0005248_abnormal_Harderian_gland | 0.32640870 |
103 | MP0002970_abnormal_white_adipose | 0.31811100 |
104 | MP0002332_abnormal_exercise_endurance | 0.31014766 |
105 | MP0001881_abnormal_mammary_gland | 0.30550665 |
106 | MP0000427_abnormal_hair_cycle | 0.30479686 |
107 | MP0001851_eye_inflammation | 0.30466488 |
108 | MP0002168_other_aberrant_phenotype | 0.29815052 |
109 | MP0002060_abnormal_skin_morphology | 0.28456315 |
110 | MP0009115_abnormal_fat_cell | 0.28213303 |
111 | MP0008872_abnormal_physiological_respon | 0.27744954 |
112 | MP0003959_abnormal_lean_body | 0.27731491 |
113 | MP0005058_abnormal_lysosome_morphology | 0.26905739 |
114 | MP0001243_abnormal_dermal_layer | 0.26905341 |
115 | MP0001845_abnormal_inflammatory_respons | 0.26753053 |
116 | MP0002128_abnormal_blood_circulation | 0.23037047 |
117 | MP0000920_abnormal_myelination | 0.18517448 |
118 | MP0003632_abnormal_nervous_system | 0.18329617 |
119 | MP0003633_abnormal_nervous_system | 0.17976896 |
120 | MP0000858_altered_metastatic_potential | 0.16891238 |
121 | MP0001986_abnormal_taste_sensitivity | 0.16727232 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Intrahepatic cholestasis (HP:0001406) | 7.71614446 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.46437208 |
3 | Deep venous thrombosis (HP:0002625) | 7.40678011 |
4 | Prolonged partial thromboplastin time (HP:0003645) | 6.76210495 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.65024387 |
6 | Xanthomatosis (HP:0000991) | 6.26209682 |
7 | Hypobetalipoproteinemia (HP:0003563) | 6.21844824 |
8 | * Complement deficiency (HP:0004431) | 5.89727027 |
9 | Hyperlipoproteinemia (HP:0010980) | 5.29764080 |
10 | Joint hemorrhage (HP:0005261) | 4.82184110 |
11 | Abnormality of the common coagulation pathway (HP:0010990) | 4.70521878 |
12 | Hypolipoproteinemia (HP:0010981) | 4.67417740 |
13 | Epidermoid cyst (HP:0200040) | 4.66913936 |
14 | Hyperammonemia (HP:0001987) | 4.49867234 |
15 | Hyperglycinemia (HP:0002154) | 4.40709627 |
16 | Fat malabsorption (HP:0002630) | 4.37047866 |
17 | Nephritis (HP:0000123) | 4.28771452 |
18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.26588522 |
19 | Ketosis (HP:0001946) | 4.24504768 |
20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.21068418 |
21 | * Abnormality of complement system (HP:0005339) | 4.18352470 |
22 | Abnormality of methionine metabolism (HP:0010901) | 4.18156962 |
23 | Abnormality of the intrinsic pathway (HP:0010989) | 4.08921442 |
24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.06838806 |
25 | Hypoalphalipoproteinemia (HP:0003233) | 4.06414867 |
26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.03705294 |
27 | Hypoglycemic coma (HP:0001325) | 3.97515829 |
28 | Conjugated hyperbilirubinemia (HP:0002908) | 3.90205925 |
29 | Hyperglycinuria (HP:0003108) | 3.77303413 |
30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.76599582 |
31 | Abnormality of glycine metabolism (HP:0010895) | 3.76599582 |
32 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.72094500 |
33 | Hypercholesterolemia (HP:0003124) | 3.43406033 |
34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.41364569 |
35 | Hyperbilirubinemia (HP:0002904) | 3.32543330 |
36 | Steatorrhea (HP:0002570) | 3.31227788 |
37 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.24095286 |
38 | Systemic lupus erythematosus (HP:0002725) | 3.19627218 |
39 | Spontaneous abortion (HP:0005268) | 3.15543459 |
40 | Hypochromic microcytic anemia (HP:0004840) | 3.11262781 |
41 | Ketoacidosis (HP:0001993) | 3.09148335 |
42 | Abnormality of serum amino acid levels (HP:0003112) | 3.04612135 |
43 | Hepatocellular carcinoma (HP:0001402) | 3.01574368 |
44 | Myocardial infarction (HP:0001658) | 2.98629364 |
45 | Abnormality of nucleobase metabolism (HP:0010932) | 2.97060463 |
46 | Skin nodule (HP:0200036) | 2.97029143 |
47 | Delayed CNS myelination (HP:0002188) | 2.95950213 |
48 | Hypoglycemic seizures (HP:0002173) | 2.72748087 |
49 | Purpura (HP:0000979) | 2.67521901 |
50 | Acanthocytosis (HP:0001927) | 2.66004300 |
51 | Neonatal hypoglycemia (HP:0001998) | 2.65431940 |
52 | Metabolic acidosis (HP:0001942) | 2.64441604 |
53 | Abnormality of purine metabolism (HP:0004352) | 2.59543445 |
54 | Abnormal gallbladder morphology (HP:0012437) | 2.55121565 |
55 | Lethargy (HP:0001254) | 2.54255745 |
56 | Osteomalacia (HP:0002749) | 2.54081118 |
57 | Fair hair (HP:0002286) | 2.54019893 |
58 | Gout (HP:0001997) | 2.53941073 |
59 | Mitral stenosis (HP:0001718) | 2.46157647 |
60 | Pulmonary embolism (HP:0002204) | 2.44918100 |
61 | Neonatal onset (HP:0003623) | 2.44418031 |
62 | Cholelithiasis (HP:0001081) | 2.42000866 |
63 | Glomerulonephritis (HP:0000099) | 2.41855123 |
64 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.40306459 |
65 | Dicarboxylic aciduria (HP:0003215) | 2.40306459 |
66 | Irritability (HP:0000737) | 2.37918513 |
67 | Spastic diplegia (HP:0001264) | 2.37746935 |
68 | Cerebral edema (HP:0002181) | 2.37334216 |
69 | Cholecystitis (HP:0001082) | 2.37121215 |
70 | Abnormal gallbladder physiology (HP:0012438) | 2.37121215 |
71 | Vascular calcification (HP:0004934) | 2.35630687 |
72 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.33401993 |
73 | Sensorimotor neuropathy (HP:0007141) | 2.27893372 |
74 | Amyloidosis (HP:0011034) | 2.25764179 |
75 | Gingival bleeding (HP:0000225) | 2.25311064 |
76 | Enlarged kidneys (HP:0000105) | 2.19698769 |
77 | Late onset (HP:0003584) | 2.19361405 |
78 | Joint swelling (HP:0001386) | 2.17951943 |
79 | Pancreatitis (HP:0001733) | 2.17195089 |
80 | Esophageal varix (HP:0002040) | 2.13832328 |
81 | Hyperglycemia (HP:0003074) | 2.13080340 |
82 | Brushfield spots (HP:0001088) | 2.11936836 |
83 | Abnormality of the gallbladder (HP:0005264) | 2.09580385 |
84 | Thrombophlebitis (HP:0004418) | 2.07885000 |
85 | Cardiovascular calcification (HP:0011915) | 2.07707777 |
86 | Menorrhagia (HP:0000132) | 2.05440941 |
87 | Malnutrition (HP:0004395) | 2.04021557 |
88 | * Recurrent gram-negative bacterial infections (HP:0005420) | 1.99021750 |
89 | Vomiting (HP:0002013) | 1.98779443 |
90 | Opisthotonus (HP:0002179) | 1.97662535 |
91 | Poikilocytosis (HP:0004447) | 1.96649109 |
92 | Epistaxis (HP:0000421) | 1.95824777 |
93 | Abnormality of the Achilles tendon (HP:0005109) | 1.93991576 |
94 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.92966998 |
95 | Generalized aminoaciduria (HP:0002909) | 1.92641230 |
96 | Hemorrhage of the eye (HP:0011885) | 1.92444342 |
97 | Increased serum ferritin (HP:0003281) | 1.92282024 |
98 | Rickets (HP:0002748) | 1.90640599 |
99 | Arthropathy (HP:0003040) | 1.87340739 |
100 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85993860 |
101 | Abnormality of iron homeostasis (HP:0011031) | 1.85074608 |
102 | Reduced antithrombin III activity (HP:0001976) | 1.84305704 |
103 | Hyperphosphaturia (HP:0003109) | 1.83420190 |
104 | Elevated hepatic transaminases (HP:0002910) | 1.83218335 |
105 | Gangrene (HP:0100758) | 1.82992726 |
106 | Abnormal cartilage morphology (HP:0002763) | 1.82577876 |
107 | Abnormality of vitamin metabolism (HP:0100508) | 1.82107986 |
108 | Symptomatic seizures (HP:0011145) | 1.81968403 |
109 | Renal cortical cysts (HP:0000803) | 1.80464108 |
110 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.79891964 |
111 | Generalized hypopigmentation of hair (HP:0011358) | 1.76084167 |
112 | Elevated alkaline phosphatase (HP:0003155) | 1.75017788 |
113 | Alkalosis (HP:0001948) | 1.73199474 |
114 | Abnormal delivery (HP:0001787) | 1.73067607 |
115 | Hypophosphatemic rickets (HP:0004912) | 1.72704648 |
116 | Status epilepticus (HP:0002133) | 1.72647468 |
117 | Cerebral palsy (HP:0100021) | 1.70333233 |
118 | Acute hepatic failure (HP:0006554) | 1.70086625 |
119 | Bifid scrotum (HP:0000048) | 1.70047390 |
120 | Abnormality of urine glucose concentration (HP:0011016) | 1.64480384 |
121 | Glycosuria (HP:0003076) | 1.64480384 |
122 | Increased mean platelet volume (HP:0011877) | 1.61825944 |
123 | Blue irides (HP:0000635) | 1.59022392 |
124 | Atrioventricular block (HP:0001678) | 1.51250705 |
125 | Increased serum pyruvate (HP:0003542) | 1.49396710 |
126 | Hydroxyprolinuria (HP:0003080) | 1.48436881 |
127 | Abnormality of proline metabolism (HP:0010907) | 1.48436881 |
128 | Abnormal urine phosphate concentration (HP:0012599) | 1.47181288 |
129 | Bile duct proliferation (HP:0001408) | 1.46944760 |
130 | Abnormal biliary tract physiology (HP:0012439) | 1.46944760 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.49465604 |
2 | ERN1 | 4.64134837 |
3 | FGFR4 | 4.52922527 |
4 | SIK1 | 4.01294409 |
5 | ERBB4 | 3.92619375 |
6 | TAOK3 | 3.64185406 |
7 | INSRR | 3.31911730 |
8 | PIK3CA | 2.44045869 |
9 | MAPK15 | 2.42188658 |
10 | MAP2K4 | 2.26928238 |
11 | MAPK11 | 2.19876231 |
12 | PIK3CG | 2.19670396 |
13 | MST1R | 2.10330702 |
14 | FRK | 1.94709223 |
15 | LATS1 | 1.86553294 |
16 | NTRK3 | 1.74105475 |
17 | FLT3 | 1.63969460 |
18 | TYK2 | 1.58461707 |
19 | NEK9 | 1.58398606 |
20 | PRPF4B | 1.46592278 |
21 | PTK6 | 1.45705492 |
22 | PKN2 | 1.42209064 |
23 | TRIB3 | 1.41991978 |
24 | ABL2 | 1.40087780 |
25 | JAK2 | 1.32560379 |
26 | NLK | 1.29786718 |
27 | ERBB2 | 1.29636539 |
28 | FGFR2 | 1.20505619 |
29 | DAPK2 | 1.20473701 |
30 | MAP3K7 | 1.15120701 |
31 | FER | 1.13913421 |
32 | TNK2 | 1.12179464 |
33 | PINK1 | 1.06783170 |
34 | PRKAA2 | 1.06593671 |
35 | EPHA3 | 1.05806596 |
36 | JAK1 | 1.04043839 |
37 | KDR | 1.01172866 |
38 | CAMKK2 | 1.00742848 |
39 | STK38L | 0.99659783 |
40 | GRK6 | 0.90692987 |
41 | MAP3K10 | 0.90486665 |
42 | PRKG1 | 0.89879483 |
43 | MET | 0.89306415 |
44 | TBK1 | 0.86581021 |
45 | MAPK4 | 0.86414804 |
46 | PRKCZ | 0.84403423 |
47 | CAMK2G | 0.83199712 |
48 | MAP3K14 | 0.81445639 |
49 | MAP3K3 | 0.80356024 |
50 | PRKACA | 0.80282491 |
51 | EPHB1 | 0.79078471 |
52 | MAP2K3 | 0.78030823 |
53 | AKT3 | 0.75624220 |
54 | DYRK1B | 0.75042357 |
55 | IRAK3 | 0.74168994 |
56 | BLK | 0.72220132 |
57 | PRKAA1 | 0.71549916 |
58 | PRKACG | 0.71336171 |
59 | CDK6 | 0.70479140 |
60 | ZAP70 | 0.70232361 |
61 | PKN1 | 0.68933057 |
62 | EPHA4 | 0.67885820 |
63 | GSK3A | 0.67805792 |
64 | PDK2 | 0.67740982 |
65 | CSK | 0.66586741 |
66 | RIPK1 | 0.64615521 |
67 | MAPK12 | 0.63561205 |
68 | SGK3 | 0.61899886 |
69 | FGFR3 | 0.61476810 |
70 | PTK2 | 0.60941127 |
71 | CAMKK1 | 0.59006737 |
72 | TIE1 | 0.58909343 |
73 | CSNK1E | 0.58895002 |
74 | CSNK1D | 0.57023495 |
75 | MAP3K13 | 0.56858317 |
76 | PRKACB | 0.55661049 |
77 | PRKCB | 0.55465014 |
78 | RPS6KA3 | 0.54191079 |
79 | MAP3K11 | 0.52511674 |
80 | MAPK7 | 0.51519880 |
81 | CAMK1D | 0.49990837 |
82 | PAK3 | 0.48798926 |
83 | PDGFRA | 0.48589532 |
84 | BRSK2 | 0.48424103 |
85 | MAP2K6 | 0.48336782 |
86 | MAP3K2 | 0.47946883 |
87 | MYLK | 0.47600886 |
88 | SRC | 0.46679778 |
89 | CSNK1G1 | 0.46233952 |
90 | MAP3K6 | 0.46095373 |
91 | WNK3 | 0.45695358 |
92 | PDPK1 | 0.45445895 |
93 | SGK2 | 0.44387595 |
94 | TAOK2 | 0.44274576 |
95 | CSNK2A1 | 0.43857077 |
96 | PRKCQ | 0.43190247 |
97 | IGF1R | 0.43174651 |
98 | SGK1 | 0.42522274 |
99 | MAP2K1 | 0.42288488 |
100 | IKBKE | 0.41762382 |
101 | MAP3K5 | 0.41092592 |
102 | IRAK1 | 0.39853621 |
103 | PRKCG | 0.39779213 |
104 | MAP3K1 | 0.39582465 |
105 | MTOR | 0.39169587 |
106 | CSF1R | 0.37638106 |
107 | RET | 0.37233559 |
108 | EGFR | 0.36410758 |
109 | SCYL2 | 0.35904303 |
110 | TGFBR2 | 0.35165730 |
111 | GRK1 | 0.34927738 |
112 | ARAF | 0.34151098 |
113 | SGK223 | 0.34042785 |
114 | SGK494 | 0.34042785 |
115 | CSNK2A2 | 0.33706645 |
116 | WNK4 | 0.32517124 |
117 | MAPK3 | 0.31380655 |
118 | CDK4 | 0.30720798 |
119 | PRKCH | 0.30201469 |
120 | ICK | 0.29474461 |
121 | MAPKAPK3 | 0.28710691 |
122 | LATS2 | 0.27046299 |
123 | AKT2 | 0.26578108 |
124 | CSNK1G2 | 0.26539890 |
125 | PRKCA | 0.25153856 |
126 | KSR2 | 0.24113740 |
127 | PDK1 | 0.23539719 |
128 | ABL1 | 0.22794688 |
129 | CSNK1G3 | 0.22699694 |
130 | CAMK4 | 0.22493582 |
131 | PDK4 | 0.21745701 |
132 | PDK3 | 0.21745701 |
133 | PBK | 0.20932233 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.87488748 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.71109588 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.46448309 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.16908054 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.13640054 |
6 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.93745884 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.73364774 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.61708262 |
9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.58408070 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.41548730 |
11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.40890245 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.33655966 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.10769541 |
14 | Peroxisome_Homo sapiens_hsa04146 | 2.10331590 |
15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.07820000 |
16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.03736588 |
17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.91595308 |
18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.87376962 |
19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.85008970 |
20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.84151181 |
21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.84037866 |
22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.81543280 |
23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.80673031 |
24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.79810850 |
25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.76582802 |
26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.72036487 |
27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.69916282 |
28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.64529824 |
29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.63618644 |
30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.62300002 |
31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.59126718 |
32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58191589 |
33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.53672081 |
34 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.49436988 |
35 | Bile secretion_Homo sapiens_hsa04976 | 1.46910014 |
36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.46820219 |
37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.43342220 |
38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.42701864 |
39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.34613186 |
40 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.31200156 |
41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.30442522 |
42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27669541 |
43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.27383158 |
44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.23201314 |
45 | ABC transporters_Homo sapiens_hsa02010 | 1.22227756 |
46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.20116013 |
47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19973255 |
48 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.15595772 |
49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.15265922 |
50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.09447981 |
51 | Carbon metabolism_Homo sapiens_hsa01200 | 1.09355466 |
52 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95448803 |
53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93384825 |
54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91177178 |
55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86983957 |
56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.85512708 |
57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81780263 |
58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78949322 |
59 | Lysine degradation_Homo sapiens_hsa00310 | 0.77267444 |
60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.74491035 |
61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67591838 |
62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65757218 |
63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60125364 |
64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56583781 |
65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47105189 |
66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46305030 |
67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45593027 |
68 | Pertussis_Homo sapiens_hsa05133 | 0.45340439 |
69 | * Prion diseases_Homo sapiens_hsa05020 | 0.45253418 |
70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41931633 |
71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25782652 |
72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24640006 |
73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24402328 |
74 | Insulin resistance_Homo sapiens_hsa04931 | 0.24330556 |
75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23643013 |
76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20829765 |
77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17259401 |
78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.16731988 |
79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.15225629 |
80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01824166 |
81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.00349849 |
82 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.2654688 |
83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2428542 |
84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.2337722 |
85 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2226982 |
86 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2185504 |
87 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2161350 |
88 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2083112 |
89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2067326 |
90 | Bladder cancer_Homo sapiens_hsa05219 | -0.2001003 |
91 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1960083 |
92 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1723590 |
93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1714617 |
94 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1711890 |
95 | Hepatitis C_Homo sapiens_hsa05160 | -0.1584715 |
96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1571903 |
97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1548665 |
98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1395428 |
99 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1230637 |
100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0910241 |
101 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0864191 |
102 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0657551 |
103 | * Amoebiasis_Homo sapiens_hsa05146 | -0.0556329 |
104 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0555777 |
105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0497454 |
106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0318642 |
107 | Mineral absorption_Homo sapiens_hsa04978 | -0.0315659 |
108 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0254065 |
109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0176497 |
110 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0157274 |